Clinical Trial Update: An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System [NA]

View source ↗

Summary

A completed clinical trial evaluating the Medtronic Resolute Integrity zotarolimus-eluting stent system for coronary artery disease with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Resolute Integrity Zotarolimus-Eluting Coronary Stent System (Zotarolimus-eluting coronary stent system)

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2015-11-25